𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase

✍ Scribed by Keith G. Watson; Rachel Cameron; Rob J. Fenton; David Gower; Stephanie Hamilton; Betty Jin; Guy Y. Krippner; Angela Luttick; Darryl McConnell; Simon J.F. MacDonald; Andy M. Mason; Van Nguyen; Simon P. Tucker; Wen-Yang Wu


Book ID
108073130
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
166 KB
Volume
14
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development of neuraminidase inhibitors
✍ Joseph N. Varghese πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 749 KB

Structure-based design and synthesis of potent influenza virus neuraminidase inhibitors are now being evaluated in human trials as anti-influenza virus drugs. The first drug of this class, Relenzaβ„’ (Zanamivir/GG167), is now awaiting pharmaceutical evaluation and registration in Australia, Europe, an